All products are 100% genuine and sourced from trusted manufacturers, with authenticity that can be verified for complete peace of mind.
Order exactly what you need with no minimum quantity required, whether itās a single unit or a larger order.
Your order is guaranteed to arrive safely, with full shipment tracking and dedicated support to ensure a smooth delivery experience.
Your payments are protected with industry-standard encryption and trusted payment providers, ensuring every transaction is safe, private, and secure.
For professional use only.
Manufacturer: Novo Nordisk
Active Substance(s): SEMAGLUTIDE
Strength: 0.5mg
Pack Size: 1 pen, 4 disposable NovoFineĀ® Plus needles (4 Doses)
Ozempic is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management.
-
Cold chain shipping available for temperature-sensitive products.
-
Orders are processed within 1ā2 business days.
-
Delivery timelines vary by destination and shipping method ā view our Shipping Policy for region-specific estimates.
-
Tracking information will be provided once shipped.
-
No order minimum applies.
-
If your shipment is delayed, lost, or arrives damaged, you're covered under our Refund & Replacement Policy.
We accept Visa, Mastercard, and American Express. Apple Pay and Google Pay are available upon request via your account manager.
All transactions are processed through a secure, PCI DSSācompliant system to ensure your data is fully protected.
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
400+ products
No order minimums
Free shipping
Loyalty rewards
Trusted since 2007
Account manager
Verified LOT numbers
INFORMATION
OZEMPICĀ® 0.5mg (Japanese): Key Features and Benefits
OZEMPICĀ® 0.5mg is an injectable medication used to improve glycemic control in individuals with type 2 diabetes. It is based on the active ingredient semaglutide, a GLP-1 receptor agonist, which helps lower blood glucose levels through various mechanisms, including stimulating insulin secretion and inhibiting glucagon release.
Key Features:
- Active Ingredient: Semaglutide.
- Available in a 0.5 mg dose, administered once a week.
- Subcutaneous injection: Can be given in the abdomen, thigh, or upper arm.
- Weight loss: Promotes weight reduction in patients with type 2 diabetes.
Benefits:
- Improves blood sugar control.
- Reduces cardiovascular risks in patients with type 2 diabetes and existing heart disease.
- Contributes to weight loss over time.
OZEMPICĀ® 0.5mg (Japanese): Indications
OZEMPICĀ® 0.5mg is primarily used to treat type 2 diabetes mellitus, especially in patients who have difficulty controlling their blood sugar through diet and exercise alone. It is also indicated for reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes and established heart disease.
Indications:
- Type 2 Diabetes Mellitus: Helps improve glycemic control.
- Cardiovascular Risk Reduction: Reduces major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in high-risk patients.
OZEMPICĀ® 0.5mg (Japanese): Ingredients
The active ingredient in OZEMPICĀ® is semaglutide. It also contains excipients to ensure stability and proper injection administration.
Ingredients:
- Semaglutide (active ingredient).
- Dibasic sodium phosphate dihydrate: Stabilizer.
- Phenol: Preservative.
- Propylene glycol: Solvent.
- Water for injections: Solvent.
OZEMPICĀ® 0.5mg (Japanese): How To Use
OZEMPICĀ® is administered once a week, at any time of the day, with or without food. It should be injected subcutaneously into the abdomen, thigh, or upper arm, and the site should be rotated to avoid irritation. The starting dose is 0.25 mg once weekly for the first four weeks, and after that, the dose can be increased to 0.5 mg. If further control is needed, the dose can be adjusted up to 2 mg.
Instructions for Use:
- Starting Dose: Begin with 0.25 mg once a week for 4 weeks.
- Increase to 0.5 mg: After 4 weeks, increase the dose to 0.5 mg.
- Injection Sites: Inject in the abdomen, thigh, or upper arm, rotating sites.
- Missed Dose: Administer within 5 days of the missed dose; otherwise, skip and resume the regular schedule.
OZEMPICĀ® 0.5mg (Japanese): Side Effects
Common side effects include gastrointestinal issues like nausea, vomiting, and diarrhea. Serious side effects include pancreatitis, thyroid cancer, and kidney injury.
Common Side Effects:
- Nausea, vomiting, diarrhea, and abdominal pain.
- Decreased appetite and fatigue.
Serious Side Effects:
- Pancreatitis: Severe abdominal pain and vomiting.
- Thyroid tumors: Including medullary thyroid carcinoma (MTC).
- Kidney injury: Due to severe gastrointestinal reactions.
OZEMPICĀ® 0.5mg (Japanese): Clinical Studies
Clinical trials have demonstrated the efficacy of OZEMPICĀ® in lowering HbA1c and promoting weight loss. The drug has shown to improve glycemic control significantly, with a reduction in HbA1c by up to 1.6%. It also contributes to weight loss, with patients losing between 2 to 5 kg on average.
Key Findings:
- HbA1c Reduction: Up to 1.6% reduction in HbA1c.
- Weight Loss: Patients lost 2-5 kg depending on the dosage.
- Cardiovascular Benefit: Significant reduction in cardiovascular events in patients with type 2 diabetes and heart disease.
OZEMPICĀ® 0.5mg (Japanese): Manufacturer Information
OZEMPICĀ® is manufactured by Novo Nordisk, a leading global pharmaceutical company specializing in diabetes care. The company has a long history of developing medications for chronic diseases like diabetes and obesity.
Manufacturer Details:
- Brand: OZEMPICĀ®.
- Manufacturer: Novo Nordisk.
- Headquarters: Denmark.
- Specialization: Diabetes, obesity, and cardiovascular treatments.
OZEMPICĀ® 0.5mg (Japanese): FAQ
How often should I inject OZEMPICĀ®?
OZEMPICĀ® should be injected once a week, at any time of day, with or without food.
Can I use OZEMPICĀ® if I have type 1 diabetes?
No, OZEMPICĀ® is not for type 1 diabetes. It is specifically used for type 2 diabetes.
What should I do if I miss a dose?
If you miss a dose, administer it within 5 days. If more than 5 days have passed, skip the dose and continue with your regular schedule.
Are there any risks associated with using OZEMPICĀ®?Ā
Yes, some serious risks include pancreatitis, thyroid tumors, and kidney injury. Gastrointestinal side effects like nausea and vomiting are also common.
Can I use OZEMPICĀ® during pregnancy? OZEMPICĀ® is not recommended during pregnancy.
If you plan to become pregnant, discontinue the medication at least 2 months before pregnancy. Always consult your doctor before making changes to your medication during pregnancy.
OZEMPICĀ® 0.5mg (Japanese): Key Features and Benefits
OZEMPICĀ® 0.5mg is an injectable medication used to improve glycemic control in individuals with type 2 diabetes. It is based on the active ingredient semaglutide, a GLP-1 receptor agonist, which helps lower blood glucose levels through various mechanisms, including stimulating insulin secretion and inhibiting glucagon release.
Key Features:
- Active Ingredient: Semaglutide.
- Available in a 0.5 mg dose, administered once a week.
- Subcutaneous injection: Can be given in the abdomen, thigh, or upper arm.
- Weight loss: Promotes weight reduction in patients with type 2 diabetes.
Benefits:
- Improves blood sugar control.
- Reduces cardiovascular risks in patients with type 2 diabetes and existing heart disease.
- Contributes to weight loss over time.
OZEMPICĀ® 0.5mg (Japanese): Indications
OZEMPICĀ® 0.5mg is primarily used to treat type 2 diabetes mellitus, especially in patients who have difficulty controlling their blood sugar through diet and exercise alone. It is also indicated for reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes and established heart disease.
Indications:
- Type 2 Diabetes Mellitus: Helps improve glycemic control.
- Cardiovascular Risk Reduction: Reduces major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in high-risk patients.
OZEMPICĀ® 0.5mg (Japanese): Ingredients
The active ingredient in OZEMPICĀ® is semaglutide. It also contains excipients to ensure stability and proper injection administration.
Ingredients:
- Semaglutide (active ingredient).
- Dibasic sodium phosphate dihydrate: Stabilizer.
- Phenol: Preservative.
- Propylene glycol: Solvent.
- Water for injections: Solvent.
OZEMPICĀ® 0.5mg (Japanese): How To Use
OZEMPICĀ® is administered once a week, at any time of the day, with or without food. It should be injected subcutaneously into the abdomen, thigh, or upper arm, and the site should be rotated to avoid irritation. The starting dose is 0.25 mg once weekly for the first four weeks, and after that, the dose can be increased to 0.5 mg. If further control is needed, the dose can be adjusted up to 2 mg.
Instructions for Use:
- Starting Dose: Begin with 0.25 mg once a week for 4 weeks.
- Increase to 0.5 mg: After 4 weeks, increase the dose to 0.5 mg.
- Injection Sites: Inject in the abdomen, thigh, or upper arm, rotating sites.
- Missed Dose: Administer within 5 days of the missed dose; otherwise, skip and resume the regular schedule.
OZEMPICĀ® 0.5mg (Japanese): Side Effects
Common side effects include gastrointestinal issues like nausea, vomiting, and diarrhea. Serious side effects include pancreatitis, thyroid cancer, and kidney injury.
Common Side Effects:
- Nausea, vomiting, diarrhea, and abdominal pain.
- Decreased appetite and fatigue.
Serious Side Effects:
- Pancreatitis: Severe abdominal pain and vomiting.
- Thyroid tumors: Including medullary thyroid carcinoma (MTC).
- Kidney injury: Due to severe gastrointestinal reactions.
OZEMPICĀ® 0.5mg (Japanese): Clinical Studies
Clinical trials have demonstrated the efficacy of OZEMPICĀ® in lowering HbA1c and promoting weight loss. The drug has shown to improve glycemic control significantly, with a reduction in HbA1c by up to 1.6%. It also contributes to weight loss, with patients losing between 2 to 5 kg on average.
Key Findings:
- HbA1c Reduction: Up to 1.6% reduction in HbA1c.
- Weight Loss: Patients lost 2-5 kg depending on the dosage.
- Cardiovascular Benefit: Significant reduction in cardiovascular events in patients with type 2 diabetes and heart disease.
OZEMPICĀ® 0.5mg (Japanese): Manufacturer Information
OZEMPICĀ® is manufactured by Novo Nordisk, a leading global pharmaceutical company specializing in diabetes care. The company has a long history of developing medications for chronic diseases like diabetes and obesity.
Manufacturer Details:
- Brand: OZEMPICĀ®.
- Manufacturer: Novo Nordisk.
- Headquarters: Denmark.
- Specialization: Diabetes, obesity, and cardiovascular treatments.
OZEMPICĀ® 0.5mg (Japanese): FAQ
How often should I inject OZEMPICĀ®?
OZEMPICĀ® should be injected once a week, at any time of day, with or without food.
Can I use OZEMPICĀ® if I have type 1 diabetes?
No, OZEMPICĀ® is not for type 1 diabetes. It is specifically used for type 2 diabetes.
What should I do if I miss a dose?
If you miss a dose, administer it within 5 days. If more than 5 days have passed, skip the dose and continue with your regular schedule.
Are there any risks associated with using OZEMPICĀ®?Ā
Yes, some serious risks include pancreatitis, thyroid tumors, and kidney injury. Gastrointestinal side effects like nausea and vomiting are also common.
Can I use OZEMPICĀ® during pregnancy? OZEMPICĀ® is not recommended during pregnancy.
If you plan to become pregnant, discontinue the medication at least 2 months before pregnancy. Always consult your doctor before making changes to your medication during pregnancy.
Related products
